Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Array Biopharma, Inc -- Ignore unavailable to you. Want to Upgrade?

To: mcbio who wrote (108)	6/13/2011 12:30:41 AM
From: scaram(o)uche	Read Replies (2) \| Respond to of 321

Seems like the expert asking the question, and the follower answering, but.... the preclinical literature re. mek inhibition is absolutely loaded with $$$$-potential obligations. I'm riding it out, thanks for your pointer re. Conway's buy. THAT'S what shareholders want to see, management teams that HOLD their incentive shares and add when and if market conditions hand them a perceived op. Kudos. Switching topics.... congrats on your pronounced lead in the contest. From what I've seen, it is richly deserved. And it seems like Crazy Pete and Rocky are ALWAYS in or near the lead..... VERY good biotech investors. Fun! Best! Rick